{"id":15546,"date":"2018-09-04T10:31:27","date_gmt":"2018-09-04T09:31:27","guid":{"rendered":"https:\/\/staging.rayner.com\/blog\/open-brexit-letter-from-rayner-ceo\/"},"modified":"2024-11-11T13:52:38","modified_gmt":"2024-11-11T13:52:38","slug":"open-brexit-letter-from-rayner-ceo","status":"publish","type":"post","link":"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/","title":{"rendered":"Open Brexit letter from Rayner CEO"},"content":{"rendered":"<p><strong>In response from the letter received from the RtHon Matt Hancock MP, Secretary of State for Health:<\/strong><\/p>\n<p>Rayner is a UK headquartered business and the only manufacturer of intraocular lenses (IOLs) in the UK, producing at a rate of one million IOLs annually in Worthing, West Sussex. It follows that we are uniquely placed to offer stability of supply during this unprecedented period of uncertainty. As a long-established business with our factory and products inspected and certified by BSI and approved by the US FDA, we routinely engage and work closely with our key suppliers to pre-empt any potential supply issues.<\/p>\n<p>Our supply review now includes active and ongoing board-level analysis of risks specific to Brexit. Reassuringly for our customers and as an avid supporter of the British medical industry, the vast majority of Rayner\u2019s supply chain is UK based, which means the residual risk of supply disruption, even in a \u2018no-deal\u2019 Brexit scenario, is relatively low. Nonetheless, in an initiative that will mitigate the risk even further, we are embarking on a stock-building exercise to bolster our UK inventory over the next 12 months. Accordingly, through a combination of active risk management and the geographic make-up of our supply chain, we do not see there being a risk of disruption for any of our product lines due to Brexit.<\/p>\n<p>We are always keen to engage directly with our customers on any matters relating to the supply of Rayner products. In the first instance please contact\u00a0<a href=\"mailto:brexit@rayner.com\">brexit@rayner.com\u00a0<\/a>and we will ensure that your needs are dealt with urgently.<\/p>\n<p>Tim Clover<\/p>\n<p>CEO &#8211; Rayner Surgical Group Limited<\/p>\n","protected":false},"excerpt":{"rendered":"<\/p>\n<p><strong>In response from the letter received from the RtHon Matt Hancock MP, Secretary of State for Health:<\/strong><\/p>\n<p>Rayner is a UK headquartered business and the only manufacturer of intraocular lenses (IOLs) in the UK, pr&#8230;<\/p>\n","protected":false},"author":300,"featured_media":14280,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[942,946],"tags":[],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v22.5 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Open Brexit Letter Addressing Ophthalmic Ompact | Rayner Global<\/title>\n<meta name=\"description\" content=\"Read Rayner\u2019s open Brexit letter, addressing the challenges and impact on the ophthalmic industry and cataract surgery in the UK and EU.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/\" \/>\n<meta property=\"og:locale\" content=\"en_GB\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Open Brexit Letter Addressing Ophthalmic Ompact | Rayner Global\" \/>\n<meta property=\"og:description\" content=\"Read Rayner\u2019s open Brexit letter, addressing the challenges and impact on the ophthalmic industry and cataract surgery in the UK and EU.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/\" \/>\n<meta property=\"og:site_name\" content=\"Rayner : Brazil\" \/>\n<meta property=\"article:published_time\" content=\"2018-09-04T09:31:27+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-11-11T13:52:38+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/FLY_9436.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1200\" \/>\n\t<meta property=\"og:image:height\" content=\"967\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"amber\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"amber\" \/>\n\t<meta name=\"twitter:label2\" content=\"Estimated reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/\",\"url\":\"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/\",\"name\":\"Open Brexit Letter Addressing Ophthalmic Ompact | Rayner Global\",\"isPartOf\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/FLY_9436.jpg\",\"datePublished\":\"2018-09-04T09:31:27+00:00\",\"dateModified\":\"2024-11-11T13:52:38+00:00\",\"author\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/dd772238db3d508f49362c2d4b0c6ecf\"},\"description\":\"Read Rayner\u2019s open Brexit letter, addressing the challenges and impact on the ophthalmic industry and cataract surgery in the UK and EU.\",\"breadcrumb\":{\"@id\":\"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/#breadcrumb\"},\"inLanguage\":\"en-GB\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/#primaryimage\",\"url\":\"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/FLY_9436.jpg\",\"contentUrl\":\"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/FLY_9436.jpg\",\"width\":1200,\"height\":967},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/rayner.com\/br-pt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Open Brexit letter from Rayner CEO\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/rayner.com\/br-pt\/#website\",\"url\":\"https:\/\/rayner.com\/br-pt\/\",\"name\":\"Rayner : Brazil\",\"description\":\"Rayner is a British manufacturer of ophthalmic medical products, including intraocular lenses (IOLs) and eye drops to support ocular health\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/rayner.com\/br-pt\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-GB\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/dd772238db3d508f49362c2d4b0c6ecf\",\"name\":\"amber\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-GB\",\"@id\":\"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/2a37c62d44baf342de3f73e35506d275?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/2a37c62d44baf342de3f73e35506d275?s=96&d=mm&r=g\",\"caption\":\"amber\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Open Brexit Letter Addressing Ophthalmic Ompact | Rayner Global","description":"Read Rayner\u2019s open Brexit letter, addressing the challenges and impact on the ophthalmic industry and cataract surgery in the UK and EU.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/","og_locale":"en_GB","og_type":"article","og_title":"Open Brexit Letter Addressing Ophthalmic Ompact | Rayner Global","og_description":"Read Rayner\u2019s open Brexit letter, addressing the challenges and impact on the ophthalmic industry and cataract surgery in the UK and EU.","og_url":"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/","og_site_name":"Rayner : Brazil","article_published_time":"2018-09-04T09:31:27+00:00","article_modified_time":"2024-11-11T13:52:38+00:00","og_image":[{"width":1200,"height":967,"url":"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/FLY_9436.jpg","type":"image\/jpeg"}],"author":"amber","twitter_card":"summary_large_image","twitter_misc":{"Written by":"amber","Estimated reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/","url":"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/","name":"Open Brexit Letter Addressing Ophthalmic Ompact | Rayner Global","isPartOf":{"@id":"https:\/\/rayner.com\/br-pt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/#primaryimage"},"image":{"@id":"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/#primaryimage"},"thumbnailUrl":"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/FLY_9436.jpg","datePublished":"2018-09-04T09:31:27+00:00","dateModified":"2024-11-11T13:52:38+00:00","author":{"@id":"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/dd772238db3d508f49362c2d4b0c6ecf"},"description":"Read Rayner\u2019s open Brexit letter, addressing the challenges and impact on the ophthalmic industry and cataract surgery in the UK and EU.","breadcrumb":{"@id":"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/#breadcrumb"},"inLanguage":"en-GB","potentialAction":[{"@type":"ReadAction","target":["https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/"]}]},{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/#primaryimage","url":"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/FLY_9436.jpg","contentUrl":"https:\/\/rayner.com\/br-pt\/wp-content\/uploads\/sites\/29\/2021\/11\/FLY_9436.jpg","width":1200,"height":967},{"@type":"BreadcrumbList","@id":"https:\/\/rayner.com\/br-pt\/open-brexit-letter-from-rayner-ceo\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/rayner.com\/br-pt\/"},{"@type":"ListItem","position":2,"name":"Open Brexit letter from Rayner CEO"}]},{"@type":"WebSite","@id":"https:\/\/rayner.com\/br-pt\/#website","url":"https:\/\/rayner.com\/br-pt\/","name":"Rayner : Brazil","description":"Rayner is a British manufacturer of ophthalmic medical products, including intraocular lenses (IOLs) and eye drops to support ocular health","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/rayner.com\/br-pt\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-GB"},{"@type":"Person","@id":"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/dd772238db3d508f49362c2d4b0c6ecf","name":"amber","image":{"@type":"ImageObject","inLanguage":"en-GB","@id":"https:\/\/rayner.com\/br-pt\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/2a37c62d44baf342de3f73e35506d275?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/2a37c62d44baf342de3f73e35506d275?s=96&d=mm&r=g","caption":"amber"}}]}},"_links":{"self":[{"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/posts\/15546"}],"collection":[{"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/users\/300"}],"replies":[{"embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/comments?post=15546"}],"version-history":[{"count":1,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/posts\/15546\/revisions"}],"predecessor-version":[{"id":15737,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/posts\/15546\/revisions\/15737"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/media\/14280"}],"wp:attachment":[{"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/media?parent=15546"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/categories?post=15546"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/rayner.com\/br-pt\/wp-json\/wp\/v2\/tags?post=15546"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}